CT-2103 [polyglutamate paclitaxel]/carboplatin vs paclitaxel/carboplatin for the treatment of PS = 2 patients with chemotherapy naive advanced non-small cell lung cancer (NSCLC): a phase III study
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms STELLAR-3
- Sponsors CTI BioPharma
- 02 Oct 2020 Status changed from active, no longer recruiting to discontinued.
- 01 Jun 2008 Results have been published
- 02 Oct 2005 New trial record.